D. Volles

Pharmacokinetic considerations.

D. Volles, R. McGory, 1999, Critical care clinics.

Establishing an institution-specific therapeutic range for heparin.

J. Humphries, D. Volles, C. J. Ancell, 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Analytic and Clinical Performance of Two Compact Cholesterol‐Testing Devices

J. Mckenney, W. Miller, D. Volles, 1998, Pharmacotherapy.

Use of otoacoustic emissions to screen for hearing loss in critically ill patients.

R. Hamill-Ruth, R. Ruth, D. Volles, 1998, Audiology : official organ of the International Society of Audiology.

Stability of Cefepime in Peritoneal Dialysis Solution

D. Haverstick, P. L. Lynch, D. Volles, 1999, The Annals of pharmacotherapy.

Collaborative Antimicrobial Stewardship for Surgeons.

R. Sawyer, A. Mathers, D. Volles, 2020, Infectious disease clinics of North America.

Usefulness of laboratory values in predicting effectiveness of recombinant factor VIIa in surgical patients with bleeding.

D. Volles, Sarah N Gruber, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Analysis of a new best-practice advisory on time to initiation of antibiotics in surgical intensive care unit patients with septic shock

D. Volles, Tyler Chanas, Rob Sawyer, 2019, Journal of the Intensive Care Society.

Use of Erythropoietin in the Severely Anemic Jehovah's Witness Patient: Case Report and Review of the Literature

P. D. Rogers, D. Volles, 1997 .

Antibiotics in the intensive care unit: focus on agents for resistant pathogens.

D. Volles, Trisha N. Branan, Trisha Branan, 2008, Emergency medicine clinics of North America.

Role of Recombinant Human Activated Protein C (Drotrecogin Alfa, Activated, Xigris®) for Severe Sepsis

D. Volles, B. C. Strickland, 2007 .